162 related articles for article (PubMed ID: 34235662)
1. CRISPR Interference (CRISPRi) for Targeted Gene Silencing in Mycobacteria.
Wong AI; Rock JM
Methods Mol Biol; 2021; 2314():343-364. PubMed ID: 34235662
[TBL] [Abstract][Full Text] [Related]
2. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform.
Rock JM; Hopkins FF; Chavez A; Diallo M; Chase MR; Gerrick ER; Pritchard JR; Church GM; Rubin EJ; Sassetti CM; Schnappinger D; Fortune SM
Nat Microbiol; 2017 Feb; 2():16274. PubMed ID: 28165460
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel CRISPRi-based tool for silencing of multiple genes in Mycobacterium tuberculosis.
Agarwal N
Plasmid; 2020 Jul; 110():102515. PubMed ID: 32535164
[TBL] [Abstract][Full Text] [Related]
4. A Cas12a-based CRISPR interference system for multigene regulation in mycobacteria.
Fleck N; Grundner C
J Biol Chem; 2021 Aug; 297(2):100990. PubMed ID: 34298016
[TBL] [Abstract][Full Text] [Related]
5. Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi).
Hawkins JS; Wong S; Peters JM; Almeida R; Qi LS
Methods Mol Biol; 2015; 1311():349-62. PubMed ID: 25981485
[TBL] [Abstract][Full Text] [Related]
6. Gene silencing by CRISPR interference in mycobacteria.
Choudhary E; Thakur P; Pareek M; Agarwal N
Nat Commun; 2015 Feb; 6():6267. PubMed ID: 25711368
[TBL] [Abstract][Full Text] [Related]
7. A CRISPR Interference System for Efficient and Rapid Gene Knockdown in Caulobacter crescentus.
Guzzo M; Castro LK; Reisch CR; Guo MS; Laub MT
mBio; 2020 Jan; 11(1):. PubMed ID: 31937638
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the CRISPR-Associated Genes by Rv2837c (CnpB) via an Orn-Like Activity in Tuberculosis Complex Mycobacteria.
Zhang Y; Yang J; Bai G
J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378893
[TBL] [Abstract][Full Text] [Related]
9. A multiplex CRISPR interference tool for virulence gene interrogation in Legionella pneumophila.
Ellis NA; Kim B; Tung J; Machner MP
Commun Biol; 2021 Feb; 4(1):157. PubMed ID: 33542442
[TBL] [Abstract][Full Text] [Related]
10. Programmable Gene Knockdown in Diverse Bacteria Using Mobile-CRISPRi.
Banta AB; Ward RD; Tran JS; Bacon EE; Peters JM
Curr Protoc Microbiol; 2020 Dec; 59(1):e130. PubMed ID: 33332762
[TBL] [Abstract][Full Text] [Related]
11. Strategies of genome editing in mycobacteria: Achievements and challenges.
Choudhary E; Lunge A; Agarwal N
Tuberculosis (Edinb); 2016 May; 98():132-8. PubMed ID: 27156629
[TBL] [Abstract][Full Text] [Related]
12. Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection.
Cheung CY; McNeil MB; Cook GM
J Antimicrob Chemother; 2022 Feb; 77(3):615-619. PubMed ID: 34850009
[TBL] [Abstract][Full Text] [Related]
13. Application of the CRISPRi system to repress sepF expression in Mycobacterium smegmatis.
Xiao J; Jia H; Pan L; Li Z; Lv L; Du B; Zhang L; Du F; Huang Y; Cao T; Sun Q; Wei R; Xing A; Zhang Z
Infect Genet Evol; 2019 Aug; 72():183-190. PubMed ID: 31242975
[TBL] [Abstract][Full Text] [Related]
14. Development and implementation of a Type I-C CRISPR-based programmable repression system for
Geslewitz WE; Cardenas A; Zhou X; Zhang Y; Criss AK; Seifert HS
mBio; 2024 Feb; 15(2):e0302523. PubMed ID: 38126782
[TBL] [Abstract][Full Text] [Related]
15. CRISPR interference (CRISPRi) for sequence-specific control of gene expression.
Larson MH; Gilbert LA; Wang X; Lim WA; Weissman JS; Qi LS
Nat Protoc; 2013 Nov; 8(11):2180-96. PubMed ID: 24136345
[TBL] [Abstract][Full Text] [Related]
16. Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in
McNeil MB; Cook GM
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160289
[TBL] [Abstract][Full Text] [Related]
17. Multiplex CRISPRi System Enables the Study of Stage-Specific Biofilm Genetic Requirements in Enterococcus faecalis.
Afonina I; Ong J; Chua J; Lu T; Kline KA
mBio; 2020 Oct; 11(5):. PubMed ID: 33082254
[No Abstract] [Full Text] [Related]
18. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
Bendixen L; Jensen TI; Bak RO
Mol Ther; 2023 Jul; 31(7):1920-1937. PubMed ID: 36964659
[TBL] [Abstract][Full Text] [Related]
19. Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.
Daniel C; Willcocks S; Bhakta S
Methods Mol Biol; 2024; 2833():23-33. PubMed ID: 38949697
[TBL] [Abstract][Full Text] [Related]
20. The New State of the Art: Cas9 for Gene Activation and Repression.
La Russa MF; Qi LS
Mol Cell Biol; 2015 Nov; 35(22):3800-9. PubMed ID: 26370509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
